DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Akme Fintrade (India) Limited — Key licenses/regulatory approvals (Sub-para 12-Para B)

NSE 51 min ago·9 Oct 2026, 5:39 am

Akme Fintrade (India)

Akme Fintrade (India) Limited has informed stock exchanges that it has obtained key regulatory licenses and approvals. This development is a significant milestone for the company as it validates its compliance with necessary legal frameworks. The firm has submitted this disclosure to ensure transparency and keep investors informed about its operational status.

For investors, this news is generally viewed positively as it removes regulatory uncertainty. Securing these approvals is a prerequisite for the company to continue its business operations and growth plans without interruption. It signals that the company is adhering to the required standards, which can boost confidence among stakeholders.

Investors should monitor the company's future announcements for details on how these approvals will be utilized. While the current disclosure confirms compliance, the next steps will likely involve the execution of business strategies that depend on these clear regulatory standing. Keeping an eye on the company's operational updates will be key.